CTD HOLDINGS INC Business Finance Contracts & Agreements

80 Contracts & Agreements

Browse by Subcategory

Equity Distribution Agreements (1 contract)
Guaranty Agreements (2)
Loan Agreements (19)
Note Agreements (20)
Purchase Agreements (11)
Registration Rights Agreements (2)
Security Agreements (2)
Underwriting Agreements (4)
Warrant Agreements (19)

Recent Contracts

Convertible Promissory Note dated January 3, 2025 payable to Rafael Holdings, Inc (Filed With SEC on January 3, 2025)
Seventh Amended and Restated Note Purchase Agreement dated as of January 3, 2025 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on January 3, 2025)
Amendment to Convertible Promissory Notes dated as of December 21, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on December 23, 2024)
Convertible Promissory Note dated December 5, 2024 payable to Rafael Holdings, Inc (Filed With SEC on December 5, 2024)
Sixth Amended and Restated Note Purchase Agreement dated as of December 5, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on December 5, 2024)
Convertible Promissory Note dated November 7, 2024 payable to Rafael Holdings, Inc (Filed With SEC on November 8, 2024)
Fifth Amended and Restated Note Purchase Agreement dated as of November 7, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on November 8, 2024)
Amendment to Convertible Promissory Notes dated as of October 8, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on October 8, 2024)
Convertible Promissory Note dated October 8, 2024 payable to Rafael Holdings, Inc (Filed With SEC on October 8, 2024)
Fourth Amended and Restated Note Purchase Agreement dated as of October 8, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on October 8, 2024)
Convertible Promissory Note dated September 9, 2024 payable to Rafael Holdings, Inc (Filed With SEC on September 9, 2024)
Third Amended and Restated Note Purchase Agreement dated as of September 9, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on September 9, 2024)
Convertible Promissory Note dated August 21, 2024 payable to Rafael (Filed With SEC on August 22, 2024)
Second Amended and Restated Note Purchase Agreement dated as of August 21, 2024 by and among the Company and Rafael (Filed With SEC on August 22, 2024)
Convertible Promissory Note dated July 16, 2024 payable to Rafael Holdings, Inc (Filed With SEC on July 17, 2024)
Amended and Restated Note Purchase Agreement dated as of July 16, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on July 17, 2024)
Convertible Promissory Note dated June 11, 2024 payable to Rafael Holdings, Inc (Filed With SEC on June 11, 2024)
Note Purchase Agreement dated as of June 11, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on June 11, 2024)
Form of Purchase Agreement (Filed With SEC on October 20, 2023)
Form of New Warrant (Filed With SEC on October 20, 2023)
Warrant issued to Rafael Holdings, Inc., dated August 1, 2023 (Filed With SEC on August 3, 2023)
Securities Purchase Agreement, dated as of June 1, 2023, between Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on June 5, 2023)
Form of Warrant issuable to Rafael Holdings, Inc. under Securities Purchase Agreement dated June 1, 2023 (Filed With SEC on June 5, 2023)
Registration Rights Agreement, dated as of May 2, 2023, between Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on May 4, 2023)
Securities Purchase Agreement, dated as of May 2, 2023, between Cyclo Therapeutics, Inc. and Rafael Holdings, Inc (Filed With SEC on May 4, 2023)
Warrant, dated May 2, 2023, issued by Cyclo Therapeutics, Inc. to Rafael Holdings, Inc (Filed With SEC on May 4, 2023)
Securities Purchase Agreement, dated as of April 20, 2023, between Cyclo Therapeutics, Inc. and purchasers party thereto (Filed With SEC on April 24, 2023)
Form of Warrant, dated April 20, 2023, issued by Cyclo Therapeutics, Inc (Filed With SEC on April 24, 2023)
Securities Purchase Agreement dated December 29, 2022 (Filed With SEC on January 3, 2023)
Form of Placement Agent Warrant (Filed With SEC on January 3, 2023)
Form of Series A-2 Warrant (Filed With SEC on January 3, 2023)
Form of Series A-1 Warrant (Filed With SEC on January 3, 2023)
Form of Pre-Funded Warrant (Filed With SEC on January 3, 2023)
Form of pre-funded warrant (Filed With SEC on November 21, 2022)
Form of common warrant (Filed With SEC on November 21, 2022)
Form of Underwriting Agreement (Filed With SEC on November 21, 2022)
Underwriting Agreement, dated November 16, 2021, between Cyclo Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on November 19, 2021)
Equity Distribution Agreement, dated as of August 16, 2021, between Cyclo Therapeutics, Inc. and Oppenheimer & Co. Inc (Filed With SEC on August 16, 2021)
Warrant Agency Agreement (Filed With SEC on December 11, 2020)
Underwriters Warrant (Filed With SEC on December 11, 2020)